Response To Treatment With Mepolizumab In Elderly Patients

被引：0
|
作者：
Ortega, H. [1 ]
Mayer, B. [2 ]
Yancey, S. [1 ]
Katial, R. [3 ]
机构：
[1] GlaxoSmithKline, Res Triangle Pk, NC USA
[2] GlaxoSmithKline, Stockley Pk, England
[3] Natl Jewish Hlth, Denver, CO USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4177
引用
收藏
页数：1
相关论文
共 50 条
  • [31] RESPONSE TO RESLIZUMAB IN SEVERE ASTHMA PATIENTS UNRESPONSIVE TO MEPOLIZUMAB OR WITH SUSPECTED VASCULITIS
    Hama, B.
    Thomas, N.
    Elsey, L.
    Hince, K.
    Waye, R.
    Allen, D.
    Holmes, L.
    Pantin, T.
    Tavernier, G.
    Fowler, S.
    Niven, R.
    THORAX, 2019, 74 : A140 - A140
  • [32] The influence of Adherence to inhaled Corticosteroids (ICS) on treatment Response to mepolizumab treatment in severe Eosinophilic asthma
    Almutairi, Mohammed
    Marriott, John
    Jalal, Zahraa
    Wood, Louise
    Almoosawi, Batool
    Caddick, Samantha
    Rajkumari, Babita
    Renwick, Susan
    Wilkinson, Siobhan
    Gallagher, Caroline
    Duffin, Thomas
    Mansur, Adel
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [33] SingleNucleotide Polymorphisms as Biomarkers of Mepolizumab and Benralizumab Treatment Response in Severe Eosinophilic Asthma
    Rojo-Tolosa, Susana
    Sanchez-Martinez, Jose Antonio
    Caballero-Vazquez, Alberto
    Pineda-Lancheros, Laura Elena
    Gonzalez-Gutierrez, Maria Victoria
    Perez-Ramirez, Cristina
    Jimenez-Morales, Alberto
    Morales-Garcia, Concepcion
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [34] Multiple myeloma in the elderly: Clinical features and response to treatment in 113 patients
    Clavio, M
    Casciaro, S
    Gatti, AM
    Spriano, M
    Bonanni, F
    Poggi, A
    Vallebella, E
    Pietrasanta, D
    Prencipe, E
    Goretti, R
    Vimercati, R
    Rossi, E
    Masoudi, B
    Ghio, R
    Boccaccio, P
    Ricciari, S
    Damasio, E
    Gobbi, M
    HAEMATOLOGICA, 1996, 81 (03) : 238 - 244
  • [35] Treatment, outcome and predictors of response in elderly depressed in-patients - Reply
    Heeren, TJ
    Derksen, P
    TenHam, BFV
    VanGent, PPJ
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 289 - 290
  • [36] Durability of Clinical Response Following Long-Term Treatment with Mepolizumab in Patients with Severe Eosinophilic Asthma: The COLUMBA Study
    Albers, F. C.
    Ortega, H.
    Bradford, E. S.
    Gilson, M. J.
    Price, R. G.
    Yancey, S. W.
    Moore, W. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [37] Treatment of Eosinophilic Myositis with Mepolizumab
    Waheed, Saadia
    Zubair, Hafiz Muhammad
    Waheed, Farishta
    INDIAN JOURNAL OF RHEUMATOLOGY, 2018, 13 (04) : 289 - 290
  • [38] Response to mepolizumab treatment is sustained across 4-weekly dosing periods
    Pavord, Ian D.
    Bleecker, Eugene R.
    Buhl, Roland
    Chanez, Pascal
    Bel, Elisabeth H.
    Howarth, Peter
    Bratton, Daniel J.
    Albers, Frank C.
    Yancey, Steven
    ERJ OPEN RESEARCH, 2020, 6 (03) : 1 - 8
  • [39] Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma
    Hamada, Yuto
    Gibson, Peter G.
    Harvey, Erin S.
    Stevens, Sean
    Lewthwaite, Hayley
    Fricker, Michael
    Mcdonald, Vanessa M.
    Gillman, Andrew
    Hew, Mark
    Kritikos, Vicky
    Upham, John W.
    Thomas, Dennis
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (02):
  • [40] THE VALUE OF ORAL PREDNISOLONE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA ON MEPOLIZUMAB TREATMENT
    Yang, J. F.
    Busby, J.
    Heaney, L. G.
    Brightling, C. E.
    Pavord, I. D.
    Borg, K.
    McDowell, P. J.
    Diver, S.
    Shrimanker, R.
    Smith, S. J.
    Shepherd, M.
    Lee, W. N.
    Chaudhuri, R.
    THORAX, 2021, 76 : A141 - A141
12345